Evidence map›Paper›PMID 40687411›Full record

ArticleCureus2025

Serum Progranulin as a Potential Diagnostic Predictor in Neonatal Sepsis.

Dandan Bei, Yan Cheng, Ruoxuan Jiang, Huafeng Wang

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dandan BeiDepartment of Neonatology, The Second Hospital of Anhui Medical University, Hefei, CHN.
Yan ChengDepartment of Neonatology, The Second Hospital of Anhui Medical University, Hefei, CHN.
Ruoxuan JiangDepartment of Neonatology, The Second Hospital of Anhui Medical University, Hefei, CHN.
Huafeng WangDepartment of Neonatology, The Second Hospital of Anhui Medical University, Hefei, CHN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe study aimed to evaluate the diagnostic and prognostic power of progranulin (PGRN) in neonatal sepsis.

methodsWe enrolled 67 newborns hospitalized for sepsis or suspected infection. Serum biomarkers, including PGRN, were quantified at admission. The relationship between PGRN levels and sepsis severity, hospital stay duration, and diagnostic accuracy was analyzed.

resultsNeonates with sepsis exhibited elevated PGRN concentrations, which correlated directly with prolonged hospitalization. PGRN emerged as a robust prognostic biomarker for neonatal sepsis, indicating the highest predictive power (AUC: 0.956; 95% CI: 0.875-0.991;

conclusionThis study indicated that PGRN may be an excellent biomarker for early diagnosis and guiding clinical management of neonatal sepsis.

Indexed as

biological markerneonatal sepsisnlrprogranulinwbc

Identifiers

PMID40687411
PMCPMC12276716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.